Sagittarius Life Science Corp

NT$44.00As of Sun 8 Nov 2026, 12:00 UTC
TPEx:3205Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (9.00%)
Div yield —
ROE (1.72%)
Biotechnology
Beta (5Y) 0.29
PE TTM —
TSR TTM (15.87%)
Mkt cap NT$2.972B
ROIC (4.99%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$49
12.24%
(72.65%)
Hold 6|6|3|7|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.94
0.98
1.06
1.12
26.94%
26.62%
33.76%
31.84%
RevenueNT$M
167.0
172.7
179.8
176.3
1.88%
4.23%
5.63%
5.35%
Peers (US$89.76M)
Cap (US$)
PE
88.97M
—
Capital
TTM
5Y
10Y
Leveragex
2.392
(0.053)
(0.045)
EBIT/Intx
0.292
1.703
1.682
Own earn%
90.45
64.29
15.92
Sh yield%
17.30
29.19
27.35
Owners
Insiders/Inst%
3.21
89.48
Short interest%
5.60
SBC / revenue%
4.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
10–15
$1 testx
0.0
Incr. ROIC%
4